Association between tumor-associated macrophages and microvessel density on prostate cancer progression  by Yuri, Prahara et al.
lable at ScienceDirect
Prostate Int 3 (2015) 93e98Contents lists avaiProstate International
journal homepage: http: / /p- internat ional .org.Original ArticleAssociation between tumor-associated macrophages and microvessel
density on prostate cancer progression
Prahara Yuri 1, *, Ahmad Zulfan Hendri 2, Raden Danarto 2
1 Department of Urology, Faculty of Medicine, University of Indonesia, Sardjito Hospital, Yogyakarta, Indonesia
2 Department of Urology, Faculty of Medicine, Gajah Mada University, Sardjito Hospital, Yogyakarta, Indonesiaa r t i c l e i n f o
Article history:
Received 23 April 2015
Accepted 4 June 2015
Available online 28 July 2015
Keywords:
High-grade prostatic intraepithelial
neoplasia
Microvessel density
Prostate cancer
Tumor-associated macrophage* Corresponding author. Department of Urology, Fa
of Indonesia, Diponegoro Street Number 71, Jakarta 1
E-mail address: prahara.yuri@gmail.com (P Yuri).
http://dx.doi.org/10.1016/j.prnil.2015.06.002
p2287-8882 e2287-903X/Copyright © 2015 Asian Pa
creativecommons.org/licenses/by-nc-nd/4.0/).a b s t r a c t
Background: To evaluate tumor-associated macrophages (TAMs) inﬁltration and microvessel density as
possible prognostic factors related to prostate cancer (PCa) progression.
Methods: Immunostaining of TAMs in prostate biopsy specimens was performed using a monoclonal
antibody CD68 and microvessel density (MVD) using von Willebrand factor (vWF) from 25 specimens
with high-grade prostatic intraepithelial neoplasia (HGPIN) and 25 specimens with PCa after transure-
thral resection of the prostate (TURP). Six microscopic (200) ﬁelds were selected for TAM counting and
six microscopic (100) ﬁelds were selected for MVD counting around the cancer foci. Association be-
tween age, preoperative prostate-speciﬁc antigen (PSA), pathologic Gleason sum (GS), TAM, MVD,
extracapsular extension, and metastasis were assessed using Pearson/Spearman, Student t test/Mann-
Whitney U test and one-way analysis of variance/Kruskal-Wallis test.
Results: The mean of age, PSA, TAMs, and MVD were 69.1± 9.9, 67.1± 92.4, 26.2± 11.9, and 31.4± 14.0,
respectively, from 50 specimens with PCa and HGPIN. Increasing TAMs number was not correlated with
increasing MVD number and there was no signiﬁcant mean difference statistically (P> 0.05) in TAMs and
MVD although the mean of TAMs number was higher in PCa versus HGPIN but signiﬁcant in PSA level
(P< 0.001). In PCa specimens, age, PSA, TAMs, and MVD number were higher in patients with metastatic
and extracapsular extension, but not signiﬁcant statistically (P> 0.005). There was no correlation be-
tween TAMs and MVD (P> 0.001).
Conclusions: TAMs and MVD had increased PCa but did not provide independent prognostic value.
Increasing numbers of TAMs was not always followed by an increase in MVD. HGPIN is the most likely
precursor for PCa.
Copyright © 2015 Asian Paciﬁc Prostate Society, Published by Elsevier. This is an open access article under
the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Prostate cancer (PCa) is the second most common disease and
the sixth leading cause of death in males, around 14% (903,500) of
the total new cancer cases of the disease and 6% (258,400) of the
total deaths caused by cancer in men at the end of 2008.1 The cause
of initiation and progression of PCa is not yet recognized; some
studies suggest that genetic factors, race, diets, and environment
factors play an important role in the development of the disease.2,3
Tumor-associated macrophages (TAM) played a signiﬁcant bio-
logical role in initiation and progressivity of tumor. However, theculty of Medicine, University
0430, Indonesia.
ciﬁc Prostate Society, Published bclinical signiﬁcance of TAM in various cancers is not yet deter-
mined. This research was designed to determine whether inﬁltra-
tion of TAM is a predictor of a disadvantageously pathological
parameter and a poor prognosis in men undergoing radical pros-
tatectomy (RP) for PCa. This research was consistent with previous
research, which reported a higher level of TAM in malignant PCa
compared to the benign tissue and higher Gleason score. The level
of TAM was higher than in prostatic intraepithelial neoplasia (PIN)
compared with benign tissue. The higher Gleason score containing
a higher number of TAMwas also comparedwith the lower Gleason
score. Although the mechanisms of TAM promoting the develop-
ment and the progression of prostate cancer is not known, animal
studies in vivo properties showed that mobilization and inﬁltration
of TAM played a key role in the development and the progression of
PCa, and a histopathological study showed that the level of TAM
positively correlated with the microvessel density (MVD).4y Elsevier. This is an open access article under the CC BY-NC-ND license (http://
Prostate Int 3 (2015) 93e9894With PCa, in addition to tumor grading, vascular invasion is also
evaluated, because the presence of malignant cells in the vessels
increases the risk of pelvic metastasis. The theory of tumor
dependence growth in angiogenesis is directed by scientists to
focus on angiogenesis inhibition as a method to control the growth
of neoplastic cell. The number of angiogenesis tumors can be
measured quantitatively with MVD techniques. In this technique,
endothelial cells have an immune reaction by immunohistochem-
ical means, and then are counted with an optical microscope. Some
studies have indicated the correlation between MVD and risk of
tumor invasion on prostate and breast cancer. Additionally, corre-
lation betweenMVD, vascular invasion, nuclear pleomorphism, and
proliferation has been observed. Although association between
MVD and the level of survival sometimes seems to be controversial,
many scientists have suggested MVD as a prognostic and a pre-
dictive factor.5
MVD, which increased in PCa tissues caused by proliferation of
neovessels and the increase of MVD was associated with the
prognosis and development of PCa, and metastasis, the degree of
the disease, and the survival rate. Thus, visualization of MVD can
improve detection and cancer grading. The Gleason score is based
on the microscopic characterization of PCa. This is the most
commonly used system for PCa grading and is an important factor
in the formulation therapy schedule and the prognosis of PCa.
Evaluation of a tumor is signiﬁcant in regarding detection and
characterization. The study of MVD in PCa showed the relationship
between the increase MVDwith the carcinoma and with the higher
tumor grade.6
The risk of ﬁnding PCa in a subsequent biopsy with HGPIN is 15
times greater than in biopsies without PIN. HGPIN shares many
biochemical and genetic changes with cancer.7 Our objective was to
evaluate TAMs inﬁltrationandmicrovessel density inHGPINandPCa.
Materials and methods
This research was a prospective analytic study with the cross-
sectional design to examine the correlation between TAMs and
MVD as well as the PCa progression. The patients in whom PCa was
diagnosed at Sardjito Hospital from 2009 to 2011 were selected.
Patients with prostate preparation after awell-processed treatment
(on the evaluation of Hematoxylin and eosin stain (HE)), were
examined for prostate speciﬁc antigen (PSA), and inspection bone
scan/scintigraphy/bone survey was performed about 2 weeks after
the treatment of transurethral resection of the prostate (TURP) and
the size of prostate was measured through transabdominal/trans-
rectal ultrasonography (TAUS/TRUS) incorporated in the research.
In our hospital, RP was rarely done during this period (2 patients).
Therefore, The RP specimen was excluded.
The extracapsular extension, seminal vesicle invasion, and
lymph node metastasis were assessed by magnetic resonance im-
aging (MRI) and/or multi-slice computer tomography (MSCT). The
prostate preparation was taken from the result of core biopsy,
prostate preparationwith the diagnosis besides PIN high-grade and
prostate adenocarcinoma, prostate adenocarcinoma preparation
consisted of prostate small tumor focus (<5 spacious point),
damaged parafﬁn block lost or impossible to cut off with micro-
tome, preparation that did not meet the requirements for the
immunohistochemical examination and the patient who had no
any completely medical record data were excluded.
TAMs comprise the macrophages in stroma tissues (peritu-
moral) assessed through immunohistochemical examination using
antibodies of anti-CD68 through screening all tumor areas and
determined six hot spot areas (area with the most populous of
positive CD68) with a weak enlargement (50), chosen under a
microscope at 200 magniﬁcation, and made the average value ofthe 6 areas around the cancer foci. MVD was an indicator of
angiogenesis assessed using average microvessel count (AMC)
methods with considering the expression of vWF at endhotelial cell
with immunohistochemical examination using antibody of vWF.
This method was performed by determining six areas straddling
the border between the tumor and normal tissues with strong
enlargement (100), and then the mean of positive expression of
vWF positive was made. Association between age, preoperative
PSA, pathologic Gleason score (GS), TAM, MVD, extracapsular
extension, and metastasis were assessed using Pearson/Spearman,
Student t/Mann-Whitney U tests, and the one-way analysis of
variance/Kruskal-Wallis test.
Results
This study had been carried out using 50 specimens consisting
of 25 specimens of prostate cancer and 25 specimens of HGPIN.
TAMs assessment was performed with immunohistochemical
staining of prostate specimens using monoclonal antibody of CD68
and the evaluation of MVD was through immunohistochemical
staining of prostate specimens using the monoclonal antibody of
vWF (Fig. 1 and 2). From this research, obtained average age, PSA,
TAMs, and MVD in all samples were 69.1± 9.9, 67.1± 92.4, 2± 11.9,
and 31.4± 14.0 respectively. In prostate cancer, there were 11 pa-
tients (44%) experiencing metastasis, 7 patients (28%) with
extracapsular extension, and 14 patients (56%) with Gleason score
8 (Table 1).
Univariate analysis
The increase of TAMs was not related to the increase of MVD
with Spearman test (P¼ 0.103) and there was no mean difference
between in the number of TAMs and MVD, between PCa and
HGPIN, though TAMs mean was higher on PCa than HGPIN
(27.6± 14.2 vs. 24.7± 9.3). Nevertheless, there were differences in
mean of PSA between PCa and HGPIN with P< 0.001 (117.5þ106.8
versus 27.1 e16.6 ±) (Table 2).
In the cancer prostate group, based on the incident of metastasis
(yes vs. no), age (70.9± 11.8 vs 68.1± 8.4), PSA (143.5± 135.9 vs.
97.0± 76.1), TAMs (32.2± 16.3 vs. 24.1± 11.7) and MVD (38.3± 20.5
vs. 25.4± 9.7), overall data had mean score higher on metastasic
patient, but statistically not signiﬁcant (P> 0.05) (Table 3).
In the PCa group, based on the extracapsular extension (yes vs.
no), age (72.3± 10.3 vs. 68.2± 9.8), PSA (148.2þ131.9 vs.
105.5± 96.9) and TAMs (32.3± 22.2 vs. 25.8± 9.9), all data had
mean score higher on patients with extracapsular extension but
statistically not signiﬁcant (P> 0.05). Mean of MVD (27.7± 15.2 vs.
32.4± 17) was higher in patients who did not experience the
extracapsular extension, but statistically not signiﬁcant (P> 0.05).
(Table 4).
For mean of age, TAMs and MVD was not higher than in the
Gleason score, except for PSA which had higher mean for patients
with higher Gleason score (Table 5). On Spearman correlation
testing, no correlation was found between TAMs and MVD on
prostate cancer with metastasis (P¼ 0.157) and the extracapsular
extension (P¼ 1.492).
Discussion
The increase of TAM inﬁltration had been associated with the
pathological characteristics and poor prognosis in various cancers,
including breast, colorectal, and bladder cancer. However, in other
research, an inﬁltration of TAM was associated with prognosis or
did not have the prognostic value in colorectal cancer and breast
cancer. Similarly, the clinical signiﬁcance of TAM in the
Fig. 1. Coloration of immunohistochemical TAMs to specimens using monoclonal antibody of CD68 200. (A) High-grade PIN, (B) Prostate Cancer. TAM, tumor-associated mac-
rophages; PIN, prostatic intraepithelial neoplasia.
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Two previous studies indicated that the increase of TAM inﬁltration
was associated with survival-speciﬁc cancer that is associated with
aworse survival, whereas the other study found that the increase ofFig. 2. Coloration of immunohistochemical MVD to specimens using monoclonal antib
MVD, microvessel density; PIN, prostatic intraepithelial neoplasia.TAM inﬁltration in prostate tumor was a predictor of patient sur-
vival rates. These studies had been restricted by the small sample
size and the lack of treatment modality uniformity, so that it was
difﬁcult to draw a conclusion about the signiﬁcance of TAM inody von Willebrand factor (vWF) 100. (A) High-grade PIN, (B) Prostate Cancer.
Table 1
Characteristics of research variable.
Variables
Age (mean ± SD, median) 69.1 ± 8.4 (70.5)
PSA (mean ± SD, median) 67.1 ± 92,4 (34.4)
TAMs (mean ± SD, median) 26,2 ± 11.9 (24)
MVD (mean ± SD, median) 31.4 ± 14.0 (27)
Metastasis (N, %)
Yes 11 (44)
No 14 (56)
Extracapsular extension (N, %)
Yes 7 (28)
No 18 (72)
Gleason score (N, %)
6 4 (16)
7 7 (28)
 8 14 (56)
MVD, microvessel density; PSA, prostate-speciﬁc antigen; SD, standard devi-
ation; TAMs, tumor-associated macrophages.
Table 3
Univariate analysis on prostate cancer based on the incident of metastasis.
Variable Yes No P
Age (mean ± SD, median) 70.9 ± 11.8 (75) 68.1 ± 8.4 (70.5) 0.501a)
PSA (mean ± SD, median) 143.5 ± 135.9 (100) 97.0 ± 76.1 (68.8) 0.379b)
TAMs (mean ± SD, median) 32.2 ± 16.3 (29) 24.1 ± 11.7 (24.5) 0.160a)
MVD (mean ± SD, median) 38.3 ± 20.5 (33) 25.4 ± 9.7 (22.5) 0.112a)
a) Independent t-test.
b) Mann-Whitney U test.
MVD, microvessel density; PSA, prostate-speciﬁc antigen; SD, standard deviation;
TAMs, tumor-associated macrophages.
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level of TAM was positively correlated with MVD.4
The clinical signiﬁcance of TAMs and MVD in prostate cancer is
not yet determined and is still controversial. This research was
designed to determine whether inﬁltration of TAMs and the in-
crease of MVD were predictors of disadvantageous pathological
parameters and poor prognosis in men who are undergoing TURP
for PCa. Studies have been performed using 50 specimens, con-
sisting of 25 specimens of PCa and 25 specimens of HGPIN. From
this research, mean of age, PSA, TAMs, and MVD in all samples was
69.1± 9.9, 67.1± 92.4, 26.2± 11.9, and 31.4± 14.0, respectively. In
PCa, 11 patients (44%) experienced metastasis, seven patients (28%)
with extrascapsular extension, and 14 patients (56%) with Gleason
score  8. Nonomura et al8 examined TAMs inﬁltration in 71 pa-
tients with prostate cancer and obtained themedian of age 74, TAM
22, and PSA 50.1 ng/mL with 21 patients (29.6%) with 8 Gleason
score and 11 patients (15.5%) with extracapsular extension.
Previous research reported a higher level of TAM in malignant
PCa compared with benign tissues and the higher Gleason score.
The lever of TAM is higher in PIN than in benign tissues. The higher
Gleason score containing a higher number of TAM was also
compared with the lower Gleason score.4 Nonomura et al8 reported
that the median of PSA is 50.1 ng/mL and median of TAM is 22.
Survival, based on recurrence rate, was better on patients with < 22
total TAMs than with  22 total TAMs, and TAMs inﬁltration had
signiﬁcant relationships with PSA levels, and the Gleason score and
stage T in prostate cancer.8 Lissbrant et al9 found that the increase
of TAMs could be a nasty predictive factor in prostate cancer pa-
tients after undergoing TURP.9 Gannon et al10 investigated some
immune cells in the prostate after RP with or without neoadjuvant-
reducing androgen therapy, and found that the increase of TAMs
was a predictor of biochemical recurrence (PSA) on univariate test
but not a predictor on multivariate analysis.10Table 2
Univariate analysis between prostate cancer versus high-grade prostatic intra-
epithelial neoplasia.
Variable Prostate cancer High-grade PIN P
Age (mean ± SD, median) 69.4 ± 9.9 (71) 68.8 ± 6.8 (68) 0.817a)
PSA (mean ± SD, median) 117.5 ± 106.8 (87.6) 16.6 ± 27.1 (9.3) <0.001b)
TAMs (mean ± SD, median) 27.6 ± 14.2 (26) 24.7 ± 9.3 (24) 0.393a)
MVD (mean ± SD, median) 31.1 ± 16.4 (26) 31.7 ± 11.6 (28) 0.392b)
a) Independent t test.
b) Mann-Whitney U test.
MVD, microvessel density; PIN, prostatic intraepithelial neoplasia; PSA, prostate-
speciﬁc antigen; SD, standard deviation; TAMs, tumor-associated macrophages.In this research, the increase in the total of TAMswas not related
to the increase of MVD (P¼ 0.103), no mean difference was found
between the total of TAMs and MVD between PCa and HGPIN
though mean of TAMs in PCa was higher than in HGPIN, and in the
metastasis and in extracapsular extension PCa group. This research
was consistent with the study of Gollapudi et al,4 which reported
that the mean of TAMs in PCa is higher than in PIN and benign
prostate enlargement. But, TAMs inﬁltration was not predictive of
biochemical recurrence (PSA level) after RP.4 The variations noted
in TAM levels in these studies compared to our own can partly be
explained by different quantiﬁcationmethods and amount of tissue
used to determine TAM levels. There is presently no standardized
method for quantiﬁcation of TAM levels, thus making it difﬁcult to
compare studies.
In PCa, in addition to the tumor grading, the vascular invasion is
evaluated, because the existence of malignant cells in the vessels
increases the risk of pelvic bone metastasis. The theory of depen-
dence tumor growth in angiogenesis is directed by scientists to
focus on angiogenesis inhabitation as a method to control
neoplastic cell growth. The amount of tumor angiogenesis can be
measured quantitatively andMVD techniques.5 In PCa, the invasion
of vascular toward the development of cancer depends on the
extension extracapsular, the inclusion vesika vesicle, tumor size,
tumor metastasis to the lymph node, positive surgery limits, and
the grade of pathological examination.2,6 The increase of MVD in
PCa is similar as TAMs which is debatable.5,6 Previous in-
vestigations showed a weak correlation between MVD, the patho-
logical parameters, and PCa exodus.11 Muhammadnejad et al
reported that there was a relationship between MVD and vascular
invasion, and provide the predictive value in prostate cancer.5
Haese et al12 reported that MVD with immunohistochemical CD31
showed a signiﬁcant relationship between pathological stage and
the higher Gleason score. Wiedner et al13 also reported the rela-
tionship between MVD and invasive PCa and metastasis incident
with factor VII-related immunohistochemical antigens (F8-RA).
In this research, there was no MVD difference between prostate
cancer with HGPIN and in the PCa group with metastasis or
extracapsular extension. This was not in accordance with the the-
ory and research. However, this result was same as several studies
reporting that MVD is not associated with some parameters of PCaTable 4
Univariate analysis on prostate cancer based on the extracapsular extension.
Variable Yes No P
Age (mean ± SD, median) 72.3 ± 10.3 (77) 68.2 ± 9.8 (71) 0.369a)
PSA (mean ± SD, median) 148.2 ± 131.9 (120) 105.5 ± 96.9 (64.5) 0.412b)
TAMs (mean ± SD, median) 32.3 ± 22.2 (34) 25.8 ± 9.9 (25) 0.482a)
MVD (mean ± SD, median) 27.7 ± 15.2 (22) 32.4 ± 17 (27.5) 0.544a)
a) Independent t test.
b) Mann-Whitney U test.
MVD, microvessel density; PSA, prostate-speciﬁc antigen; SD, standard deviation;
TAMs, tumor-associated macrophages.
Table 5
Univariate analysis on prostate cancer based on the gleason score.
Variable 6 7 8 P
Age (mean ± SD, median) 72.3 ± 3.2 (71) 68.3 ± 12.4 (66) 69.1 ± 10.3 (74) 0.818a)
PSA (mean ± SD, median) 52.9 ± 67.9 (28.4) 78.1 ± 52.9 (50) 155.6 ± 122.5 (129.9) 0.092b)
TAMs (mean ± SD, median) 23.8 ± 5.7 (25) 33.4 ± 18.9 (38) 25.9 ± 13.1 (23.5) 0.448a)
MVD (mean ± SD, median) 33.3 ± 5.4 (34) 32.0 ± 13.5 (29) 30.0 ± 19.9 (21.5) 0.441a)
a) One-way analysis of variance.
b) Kruskal-Wallis test.
MVD, microvessel density; PSA, prostate-speciﬁc antigen; SD, standard deviation; TAMs, tumor-associated macrophages.
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penetration, PSA recurrence and survival).14 Reuben et al15 and
Luczynska et al16 reported that the increase of MVDwas not related
to the tumor stage, the Gleason score, tumor size, and invasion of
the tumor to seminal vesicles.
The absence of MVD correlation on PCa parameters in this
research could be caused by several factors involving the small size
of sample, the different method of MVD calculation, and the kind of
immunohistochemical staining used. Some theories described that
MVD was not an indicator to assess an angiogenic process in tumor
and is a reﬂection of the metabolic process of a cancer. This
description was also in contrast with a previous theory, which
stated that MVD did not represent angiogenesis activities, but only
described the distance among tumor capillaries. Oxygen and other
nutritionwere a limit or how far the distance of vascularization in a
tumor was.5,14
Currently, no research is associated with the increase of TAMs
andMVD. Nevertheless, in this research, ﬁndings suggest that there
are associations between the increase of TAMs, MVD in PCa, and
HGPIN PCa as well as in metastasis and extracapsular extension of
PCa. These ﬁndings were not in accordance with the theory
described by several studies in the literature about the importance
of TAM in PCa and histopathological studies show that the level of
TAM positively correlatedwithMVD. TAMwas obtained and kept in
the neoplastic tissue by various chemokines and cytokines such as
CCL2 and macrophage colony-stimulating factor-CSF. Initially TAM
was suspected to have tumoricidal activities, the recent evidence
showed that TAM might be involved in the development of cancer
because they released cytokine, growth factor, and extracellular
matrix protein (e.g., interleukin-6, vascular endothelial growth
factor, matrix metalloproteinases) that promote proliferation,
angiogenesis, and metastasis tumor.4
HGPIN is the most likely precursor for prostate cancer (CaP). The
incidence of HGPIN averages about 9% (range 4e16%) in prostate
biopsies, representing 115,000 new cases of HGPIN each year in the
United States. It is found predominantly (about 85%) in the pe-
ripheral zone of the prostate, much as is CaP The presence of PIN
predates CaP by 10 years or more, with low-grade PIN ﬁrst
appearing in men in their 30s. HGPIN is characterized by increased
crowding of prostatic cells that have enlarged nuclei and nucleoli
and intact to discontinuous basal cell layer.7
In addition, HGPIN shares many biochemical and genetic
changes with cancer, including chromosomal instability or abnor-
mality, macrophages, androgen receptor expression, cell prolifera-
tion, PSA expression, high molecular weight cytokeratin
expression, neovascularization and MVD, progressive loss of dif-
ferentiation, and markers to deﬁned membrane proteins (such as
heparan sulfate proteoglycan: HSPG, type IV collagen). These
indicate that basement HGPIN is a heterogeneous entity in the
prostate gland and its cancer.7
After HGPIN has been detected in a prostatic biopsy, the risk of
ﬁnding CaP in a subsequent biopsy is 15 times greater than in bi-
opsies without PIN. The presence of HGPIN in the initial biopsy
often results in repeat biopsies. For example, a study found thatabout one third of men with HGPIN on repeat biopsy have prostate
cancer, but others have found variable results. PINs associated with
increased MVD may have the potential of progressing to CaP.7
Therefore, we compare the differences of increasing TAMs and
MVD in both HGPIN as precancer lession and CaP not included BPH.
This study had several limitations. First, the results may have
been inﬂuenced by the heterogeneity of patients, immunohisto-
chemical staining techniques, and prostate specimen (only PCa and
HGPIN specimen). Second, in our center RP procedure was rare;
therefore we could not include the RP specimen. Third, this study
had fewer samples compared with the others. Owing to small
numbers of patients in our data sets, we were unable to assess for
other clinically relevant endpoints. Future studies evaluating sub-
sets of TAMs and MVD with different biological functions may
further elucidate the potential role of TAMs and MVD in PCa
development and progression.
Conclusion
TAMs and MVD were increased in PCa but could not be used as
an independent predictor. The increase of TAMs inﬁltrationwas not
always followed by the increase of micro-vascularization and in the
development of PCa. HGPIN is characterized by increased crowding
of prostatic cells that have enlarged nuclei and nucleoli, and intact
to discontinuous basal cell layer and shares many biochemical and
genetic changes with cancer. We emphasize that our conclusion is
tentative and ought to be conﬁrmed in a study of a larger sample
size beforemaking a clinical decision. This is the ﬁrst report to show
that a group of molecular markers, when used in concert, can
distinguish PINs that are precursors to CaP from those that are not.
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